Cybin, Inc. (CYBN)

1.49
0.14 10.22
AMEX
Prev Close 1.35
Open 1.41
Day Low/High 1.35 / 1.60
52 Wk Low/High 0.64 / 3.38
Volume 2.01M
Exchange AMEX
Shares Outstanding 14.20B
Market Cap 20.16M
P/E Ratio N/A
Div & Yield N.A. (N.A)

It may have a tough pill to swallow right now, but I'm still optimistic about psilocybin in general, and especially Cybin.

New technology could take out some of the pain -- and subjectivity -- for those looking to invest in this emerging line of treatments.

AdvisorShares Psychedelics ETF, which is adding Mindset Pharma and lists Cybin as a top holding, looks like a good trip.

To help readers navigate this mushrooming opportunity, I've put together a list of the top corporate leaders in the field.

If your time frame is one to five years, then this is how you need to look at your holdings amid today's action.

This stock will be a winner, but the short-term technical picture may require scaling in patiently.

I See a Direction for Compass Pathways

I See a Direction for Compass Pathways

It may have a tough pill to swallow right now, but I'm still optimistic about psilocybin in general, and especially Cybin.

I See Some Magic Happening as Psilocybin Advances

I See Some Magic Happening as Psilocybin Advances

New technology could take out some of the pain -- and subjectivity -- for those looking to invest in this emerging line of treatments.

This New ETF Is Totally a Wild

This New ETF Is Totally a Wild

AdvisorShares Psychedelics ETF, which is adding Mindset Pharma and lists Cybin as a top holding, looks like a good trip.

A 'Trip' to the Boardroom: A Look at Psychedelic Med's Top Players

A 'Trip' to the Boardroom: A Look at Psychedelic Med's Top Players

To help readers navigate this mushrooming opportunity, I've put together a list of the top corporate leaders in the field.

Am I Feeling Lucky? That's the Wrong Question

Am I Feeling Lucky? That's the Wrong Question

If your time frame is one to five years, then this is how you need to look at your holdings amid today's action.

Cybin Has a Challenging Setup, but Is Still a Long-Term Buy

Cybin Has a Challenging Setup, but Is Still a Long-Term Buy

This stock will be a winner, but the short-term technical picture may require scaling in patiently.